Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01315132 · ADVERSE EVENTS

Adverse events

A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies · Source last updated 2026-03-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
from baseline through one year after transplant
Other-event reporting threshold
5%
Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
Allogeneic Transplantation

Matched Sibling Allogeneic Transplantation Matched Sibling Allogeneic Transplantation: Patients undergoing myeloablative hematopoietic stem cell transplant from HLA identical related donors using cyclophosphamide tolerization

0 / 4632 / 4616 / 46

Group identifiers: EG000: Allogeneic Transplantation

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

    Other reported adverse events

    Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

    1. assessment Type
      NON_SYSTEMATIC_ASSESSMENT
      organ System
      Gastrointestinal disorders
      stats
      1. group Id
        EG000
        num Affected
        32
        num At Risk
        46
        num Events
        32
      term
      Mucositis
    2. assessment Type
      NON_SYSTEMATIC_ASSESSMENT
      organ System
      Gastrointestinal disorders
      stats
      1. group Id
        EG000
        num Affected
        30
        num At Risk
        46
        num Events
        35
      term
      Diarrhea
    Complete source fields
    event Groups
    1. deaths Num Affected
      16
      deaths Num At Risk
      46
      description
      Matched Sibling Allogeneic Transplantation Matched Sibling Allogeneic Transplantation: Patients undergoing myeloablative hematopoietic stem cell transplant from HLA identical related donors using cyclophosphamide tolerization
      id
      EG000
      other Num Affected
      32
      other Num At Risk
      46
      serious Num Affected
      0
      serious Num At Risk
      46
      title
      Allogeneic Transplantation
    frequency Threshold
    5
    other Events
    1. assessment Type
      NON_SYSTEMATIC_ASSESSMENT
      organ System
      Gastrointestinal disorders
      stats
      1. group Id
        EG000
        num Affected
        32
        num At Risk
        46
        num Events
        32
      term
      Mucositis
    2. assessment Type
      NON_SYSTEMATIC_ASSESSMENT
      organ System
      Gastrointestinal disorders
      stats
      1. group Id
        EG000
        num Affected
        30
        num At Risk
        46
        num Events
        35
      term
      Diarrhea
    time Frame
    from baseline through one year after transplant

    Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

    Preserved source evidence · Not medical advice